Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VS-505 vs sevelamer carbonate in hyperphosphatemia on maintenance dialysis
CTR20200180Phase 2Completed
- Sponsor
- Xi'an Libang Pharmaceutical
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AP301 in hyperphosphatemia, sponsored by Xi'an Libang Pharmaceutical. Started Sep 2020; status: completed.
02
Drugs
AP301
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on CTR20200180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200180.